Alpha-aryl-N-alkylnitrones from Centaur useful for neurological, autoimmune, inflammatory disorders May 31, 1999
Lilly discovers arylpiperazines acting as both 5-HT reuptake inhibitors, 5-HT1D antagonists May 31, 1999
Dopamine D4 receptor ligands useful for schizophrenia claimed by Neurogen and Schering-Plough May 28, 1999